is wegovy or tirzepatide better for weight loss vs. Semaglutide: Which GLP-1 Medication Right You? Zepbound beats Wegovy for weight

In some instances, however, the side effects may last much longer, including after discontinuing the drug

Some common case types include: GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Rybelsus, which have been linked to gastroparesis, bowel obstruction, and other serious stomach injuries Suboxone and buprenorphine products, which have been linked to severe tooth decay, tooth loss, and dental erosion Depo-Provera and other injectable contraceptives linked to meningioma brain tumors after long-term use Opioid medicines, including oxycodone, fentanyl, and hydrocodone, and claims tied to addiction, dependency, or wrongful death from overdose Blood thinners such as Xarelto, Pradaxa, and Eliquis, which have been linked to uncontrolled internal bleeding or hemorrhagic stroke Chemotherapy drugs like Taxotere, which have been linked to permanent hair loss and heart toxicity Antidepressants and SSRIs linked to birth defects, including heart problems and persistent pulmonary hypertension of the newborn Anticonvulsants such as Depakote and Topamax, linked to spina bifida, cleft palate, and other fetal injuries Zantac, also called ranitidine, and NDMA contamination linked to cancer Contaminated medications from compounding pharmacies and large manufacturers Drugs marketed off-label for uses that were not approved and were not backed by enough safety data Any prescription or over-the-counter medicine that caused serious and unexpected harm If you developed a serious condition such as organ damage, a heart event, cancer, a birth defect, severe stomach problems, or other major harm after taking a prescription or over-the-counter drug, there may be a link

Cycles exceeding 16 weeks without a washout carry a documented risk of receptor downregulation

The slower titration schedule of tirzepatide likely contributes to its lower nausea rates

Shima Hadidchi, MD Zepbound is designed to support weight management by helping regulate appetite and promote metabolic function

Months prior, the FDA had also taken tirzepatide, a GLP-1 and GIP dual receptor and the active ingredient in weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, off a similar shortage list